Former Company
Newport Board Group
Former Position
Partner
Alzyn LLC, a St Petersburg Florida based innovative consumer health and wellness company focusing on protecting aging brain cells, has appointed Christos Efessiou, a partner at Newport Board Group, as its Chief Marketing Officer. Speaking on behalf of the Board of Directors, Don Rosenkoetter Founder, Interim President, and Partner at Newport Board Group said "Chris is a proven senior executive with extensive expertise in developing, leading and profitably commercializing 36 new products into the global market. Among his many marketing successes was the 2005 launch of Mucinex into the professional market segment, which established a new standard. His knowledge, experience and passion for our endeavor will help ensure a commercial success." Christos's background includes senior leadership positions at Strategic Pharmaceutical Advisors, Alergos Pharmaceuticals, Strategic BioSciences, and Strategic Implications International, now part of Cardinal Health.
